D14 - Accelerating Cell Therapies in Type 1 Diabetes

Sunday, August 10, 2025

11:00 AM – 11:45 AM MT

CE/CME Hours: .75 CE

Co-Presenter(s)

Anastasia Albanese-O'Neill, PhD, APRN, CDCES (she/her/hers)

AVP, Community Screening and Clinical Trial Education
Breakthrough T1D
Gainesville, Florida

Disclosure(s): No financial relationships to disclose

Primary Presenter(s)

Sanjoy Dutta, PhD

Chief Scientific Officer
Breakthrough T1D (formerly JDRF)
New York, New York

Disclosure information not submitted.

Project Accelerate Cell Therapies, or "Project ACT," is a Breakthrough T1D initiative to dramatically speed cell therapy as T1D cures through coordinated efforts to simultaneously advance research, development, regulatory affairs, access, and adoption. Join this session to understand the current state of cell therapies in T1D care, explore Breakthrough T1D's strategy to accelerate cell therapies, and acquire knowledge of currently recruiting cell therapies.

Disclosure(s):

Anastasia Albanese-O'Neill, PhD, APRN, CDCES: No financial relationships to disclose